[Pathophysiology of intraocular neovascularization]

Area of Science:

• Ophthalmology
• Vascular Biology
• Cell Biology

Context:

• Intraocular neovascularization is a hallmark of several blinding eye diseases, including proliferative diabetic retinopathy and retinal vein occlusion.
• Understanding the pathological mechanisms of new blood vessel formation is crucial for developing effective treatments.

Purpose:

• To investigate the role of basic fibroblast growth factor (b-FGF) in inducing and regulating intraocular neovascularization.
• To characterize the cellular and molecular changes associated with neovascularization and its regression.
• To explore potential therapeutic strategies targeting neovascularization.

Summary:

• Basic fibroblast growth factor (b-FGF) induced intraocular neovascularization in animal models, characterized by fenestrated endothelial cells and increased lysosomal enzyme activity.
• Neovascularization originated from iris, ciliary body, and retinal vessels, with immunohistochemistry revealing specific markers like fibronectin, laminin, type IV collagen, and factor VIII.
• Corneal neovascularization induced by b-FGF showed regression upon removal, involving thrombus formation and endothelial cell disappearance while basement membrane persisted.

Impact:

• This research provides a deeper understanding of the pathogenesis of intraocular neovascularization, contributing to the development of novel therapeutic interventions for blinding eye conditions.
• The findings highlight the potential of targeting b-FGF signaling pathways and associated molecular markers for managing neovascular eye diseases.